Wells Fargo Downgrades Insulet to Equal-Weight, Lowers Price Target to $144

Benzinga Newsdesk www.benzinga.com Negative 81.7%

Neg 81.7% Neu 0% Pos 0%

Wells Fargo analyst Lawrence Biegelsen downgrades Insulet (NASDAQ:PODD) from Overweight to Equal-Weight and lowers the price target from $255 to $144.